CBD producer Brains Bioceutical Corp. has raised $31.9 million through an investment round.
DSM Venturing, the corporate venture arm of Royal DSM, a company focused on health, nutrition, and sustainable living, was a lead investor.
Del Morgan & Co. acted as Brains’ financial agent for the transaction.
Rick Brar, CEO and chairman of the Vancouver, British Columbia-based company, called the capital raise an “exciting milestone” for the company’s team.
“The growing demand …